Compound information
- Natural Products
- ZC2326097
- Molecular Formula
- C20H22N6OS
- Molecular Weight
- 394.157580324 g/mol
- Structure
-
- IUPAC Name
- 4-(2-methyl-4-pyridyl)-N-(3-phenyl-1,2,4-thiadiazol-5-yl)-1,4-diazepane-1-carboxamide
- InChI
- InChI=1S/C20H22N6OS/c1-15-14-17(8-9-21-15)25-10-5-11-26(13-12-25)20(27)23-19-22-18(24-28-19)16-6-3-2-4-7-16/h2-4,6-9,14H,5,10-13H2,1H3,(H,22,23,24,27)
- InChI Key
- UETXAEDYCAHCOG-UHFFFAOYSA-N
- SMILES
- Cc1cc(N2CCCN(C(=O)Nc3nc(-c4ccccc4)ns3)CC2)ccn1
- Source
- ZINC000020992437
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 28 | Ring Count | 4 |
Heteroatom Count | 8 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 6 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 74.25 Å2 | LogP | 3.719 |
LogS | -4.706 | LogD | 4.037 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.151 | Pgp substrate | 0.938 |
HIA | 0.97 | F20 % | 0.992 |
F30 % | 0.937 | Caco-2 | -4.554 |
MDCK | -5.189 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.328 | PPB | 95.775 |
VD | 1.078 | Fu | 1.63 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.986 | CYP1A2 substrate | 0.797 |
CYP2A6 substrate | 0.285 | CYP2B6 substrate | 0.739 |
CYP2C19 inhibitor | 0.938 | CYP2C19 substrate | 0.788 |
CYP2C8 substrate | 0.72 | CYP2C9 inhibitor | 0.975 |
CYP2C9 substrate | 0.423 | CYP2D6 inhibitor | 0.059 |
CYP2D6 substrate | 0.973 | CYP2E1 substrate | 0.344 |
CYP3A4 inhibitor | 0.772 | CYP3A4 substrate | 0.998 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.574 | CL | 4.442 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.602 | Hepatotoxicity | 0.771 |
Mutagenicity | 0.023 | Rat Oral Acute Toxicity | 0.138 |
FDAMDD | 0.282 | Skin Sensitization | 0.77 |
Carcinogenicity | 0.547 | Eye Corrosion | 0.003 |
Eye Irritation | 0.002 | Respiratory Toxicity | 0.992 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.418 | IGC50 | 3.197 |
LC50FM | -1.886 | LC50DM | -5.654 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.758 | NR-AR-LBD | 0.316 |
NR-AhR | 0.956 | NR-Aromatase | 0.031 |
NR-ER | 0.751 | NR-ER-LBD | 0.345 |
NR-PPAR-gamma | 0.647 | SR-ARE | 0.898 |
SR-ATAD5 | 0.876 | SR-HSE | 0.151 |
SR-MMP | 0.603 | SR-p53 | 0.503 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.